Research Article
BibTex RIS Cite

Çocuklarda COVİD-19 ile ilişkili Çoklu Sistemik İnflamatuvar Sendrom

Year 2022, Volume: 15 Issue: (Özel Sayı-1) 21. Mersin Pediatri Günleri Bildiri Kitabı, 170 - 183, 30.06.2022

Abstract

Amaç: SARS-CoV-2 ile ilişkili çoklu sistemik inflamatuvar sendrom tehlikeli ve ölümcül olarak seyredebilen yeni bir pediatrik hastalıktır. Kliniğimizde COVID-19 ile ilişkili Çoklu Sistemik İnflamatuvar Sendrom (MIS-C) tanısı alan çocukların klinik özelliklerini ve kısa dönem sonuçlarını tanımlamayı amaçladık. Yöntem: Hastanemiz Çocuk Enfeksiyon Hastalıkları Covid polikliniği ve Çocuk Acil polikliniğine 01.10.2020 ile 29.12. 2021 tarihleri arasında başvuran 1ay-18 yaş aralığında yer alan MIS-C tanısı alan 30 hasta dosyaları ve tıbbi kayıtları geriye dönük olarak tarandı. Hastaların demografik bilgileri, klinik bulguları, laboratuvar değerleri, Ekokardiyografi (EKO) bulguları ve tedavi şekilleri kaydedildi. Bulgular: Hastaların %60’ı (n= 18) erkeklerden oluşmaktadır. Yaş ortalamaları 8.07±4.38 yıl idi (1-16 yıl). Hastaların %83.3’ü (n=25) Çocuk Enfeksiyon Hastalıkları Servisi’ne, %16.7'si (n=5) Çocuk Yoğun Bakım Ünitesi’ne yatırıldı. Hastaların %66.6 (n=20)‘sında aile içi temas, %3.3’ünde (n=1) aile dışı temas saptanırken, %30’unda (n=9) herhangi bir temas öyküsü alınmadı. Hastaların %96.6’sında (n=29) COVID-19 antikor pozitif olup yalnızca 1 hastada COVID-19 Rt-PCR (gerçek zamanlı polimeraz zincir reaksiyonu) pozitif saptandı. Başvuru anında hastaların %3.3’ünde (n=1) ateş ve öksürük, %6.6’sında (n=2) ateş, öksürük ve nefes darlığı, %63.3’ünde (n=19) ateş, öksürükle beraber döküntü, konjonktivit, lenfadenopati varken ayrıca %13.3’ünde (n=4) solunum yetmezliği, %13.3’ünde (n=4) de karın ağrısı eşlik ediyordu.
Sonuç: COVID-19 ilişkili MIS-C’nin sağlıklı çocuklarda ve ergenlerde ciddi ve hayatı tehdit eden hastalığa yol açabileceği literatürde gösterilmiştir. COVID-19’un klinik bulgularının anlaşılmaya çalışıldığı salgın sürecinde MIS-C’nin geniş bir klinik spektrum gösterdiği ve farklı klinik sistem patolojileriyle hastaların başvuracağı ayırıcı tanıda akılda tutulmalıdır

References

  • 1. Eurosurveillance Editorial Team. Note from the editors: World Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern. Euro Surveill. 2020;25(5):200131e. doi:10.2807/1560-7917.ES.2020.25.5.200131e
  • 2. Ladhani SN, Amin-Chowdhury Z, Davies HG, et al. COVID-19 in children: analysis of the first pandemic peak in England. Arch Dis Child. 2020;105(12):1180-1185. doi:10.1136/archdischild-2020-320042
  • 3. Parri N, Lenge M, Buonsenso D; Coronavirus Infection in Pediatric Emergency Departments (CONFIDENCE) Research Group. Children with Covid-19 in Pediatric Emergency Departments in Italy. N Engl J Med. 2020;383(2):187-190. doi:10.1056/NEJMc2007617
  • 4. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-1242. doi:10.1001/jama.2020.2648
  • 5. Bi Q, Wu Y, Mei S, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study [published correction appears in Lancet Infect Dis. 2020 Jul;20(7):e148]. Lancet Infect Dis. 2020;20(8):911-919. doi:10.1016/S1473-3099(20)30287-5
  • 6. Sinha IP, Harwood R, Semple MG, et al. COVID-19 infection in children. Lancet Respir Med. 2020;8(5):446-447. doi:10.1016/S2213-2600(20)30152-1
  • 7. Nikolopoulou GB, Maltezou HC. COVID-19 in Children: Where do we Stand?. Arch Med Res. 2022;53(1):1-8. doi:10.1016/j.arcmed.2021.07.002
  • 8. Li H, Liu Z, Ge J. Scientific research progress of COVID-19/SARS-CoV-2 in the first five months. J Cell Mol Med. 2020;24(12):6558-6570. doi:10.1111/jcmm.15364
  • 9. Dorjee K, Kim H, Bonomo E, Dolma R. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients. PLoS One. 2020;15(12):e0243191. Published 2020 Dec 7. doi:10.1371/journal.pone.0243191
  • 10. Chen J, Jiang Q, Xia X, et al. Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation. Aging Cell. 2020;19(7):e13168. doi:10.1111/acel.13168
  • 11. Felsenstein S, Hedrich CM. COVID-19 in children and young people. Lancet Rheumatol. 2020;2(9):e514-e516. doi:10.1016/S2665-9913(20)30212-5
  • 12. Lee PI, Hu YL, Chen PY, Huang YC, Hsueh PR. Are children less susceptible to COVID-19?. J Microbiol Immunol Infect. 2020;53(3):371-372. doi:10.1016/j.jmii.2020.02.011
  • 13. Lee PI, Hu YL, Chen PY,Huang YC, Hsueh PR. Are children less susceptible to COVID-19? Microbiol Immunol Infect. 2020;53(3):371-372. doi:10.1016/j.jmii.2020.02.011
  • 14. Fang F, Luo XP. [Facing the pandemic of 2019 novel coronavirus infections: the pediatric perspectives]. Zhonghua Er Ke Za Zhi. 2020 Feb 2;58(2):81-85. Chinese. doi: 10.3760/cma.j.issn.0578-1310.2020.02.001.
  • 15. Bunyavanich S, Do A, Vicencio A. Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults. JAMA. 2020;323(23):2427-2429. doi:10.1001/jama.2020.8707
  • 16. National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases. CDC COVID-19 Science Briefs [Internet]. Atlanta (GA): Centers for Disease Control and Prevention (US); 2020-. Science Brief: Transmission of SARS-CoV-2 in K-12 Schools and Early Care and Education Programs – Updated. [Updated 2021 Dec 17]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK570438/
  • 17. Luca Cristiani, Enrica Mancino, Luigi Matera et all European Respiratory Journal 2020 55: 2000749; doi: 10.1183/13993003.00749-2020.
  • 18. de Bree LCJ, Koeken VACM, Joosten LAB, et al. Non-specific effects of vaccines: Current evidence and potential implications. Semin Immunol. 2018;39:35-43. doi:10.1016/j.smim.2018.06.002
  • 19. Benn CS, Netea MG, Selin LK, Aaby P. A small jab - a big effect: nonspecific immunomodulation by vaccines. Trends Immunol. 2013;34(9):431-439. doi:10.1016/j.it.2013.04.004
  • 20. Jin XM, Xu X. [The Society of Pediatrics, Chinese Medical Association-an intensive training programme for developmental and behavioral pediatrics]. Zhonghua Er Ke Za Zhi. 2013 Nov;51(11):879-80. Chinese.
  • 21. Karbuz A, Akkoc G, Bedir Demirdag T, et al. Epidemiological, Clinical, and Laboratory Features of Children With COVID-19 in Turkey. Front Pediatr. 2021;9:631547. Published 2021 May 7. doi:10.3389/fped.2021.631547
  • 22. Lu X, Zhang L, Du H, et al. SARS-CoV-2 Infection in Children. N Engl J Med. 2020;382(17):1663-1665. doi:10.1056/NEJMc2005073
  • 23. Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020;145(6): e20200702. doi:10.1542/peds.2020-0702
  • 24. Ding Y, Yan H, Guo W. Clinical Characteristics of Children With COVID-19: A Meta-Analysis. Front Pediatr. 2020;8:431. Published 2020 Jul 3. doi:10.3389/fped.2020.00431
  • 25. Hoang A, Chorath K, Moreira A, et al. COVID-19 in 7780 pediatric patients: A systematic review. E Clinical Medicine. 2020;24:100433. Published 2020 Jun 26. doi:10.1016/j.eclinm.2020.100433
  • 26. Korkmaz MF, Türe E, Dorum BA, Kılıç ZB. The Epidemiological and Clinical Characteristics of 81 Children with COVID-19 in a Pandemic Hospital in Turkey: an Observational Cohort Study. J Korean Med Sci. 2020;35(25):e236. Published 2020 Jun 29. doi:10.3346/jkms.2020.35.e236
  • 27. Cura Yayla BC, Özsürekçi Y, Aykaç K, et al. Characteristics and Management of Children with COVID-19 in Turkey. Balkan Med J. 2020;37(6):341-347. doi:10.4274/ balkanmedj.galenos.2020.2020.7.52
  • 28. Mustafa NM, A Selim L. Characterisation of COVID-19 Pandemic in Paediatric Age Group: A Systematic Review and Meta-Analysis. J Clin Virol. 2020;128:104395. doi:10.1016/j.jcv.2020.104395
Year 2022, Volume: 15 Issue: (Özel Sayı-1) 21. Mersin Pediatri Günleri Bildiri Kitabı, 170 - 183, 30.06.2022

Abstract

References

  • 1. Eurosurveillance Editorial Team. Note from the editors: World Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern. Euro Surveill. 2020;25(5):200131e. doi:10.2807/1560-7917.ES.2020.25.5.200131e
  • 2. Ladhani SN, Amin-Chowdhury Z, Davies HG, et al. COVID-19 in children: analysis of the first pandemic peak in England. Arch Dis Child. 2020;105(12):1180-1185. doi:10.1136/archdischild-2020-320042
  • 3. Parri N, Lenge M, Buonsenso D; Coronavirus Infection in Pediatric Emergency Departments (CONFIDENCE) Research Group. Children with Covid-19 in Pediatric Emergency Departments in Italy. N Engl J Med. 2020;383(2):187-190. doi:10.1056/NEJMc2007617
  • 4. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-1242. doi:10.1001/jama.2020.2648
  • 5. Bi Q, Wu Y, Mei S, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study [published correction appears in Lancet Infect Dis. 2020 Jul;20(7):e148]. Lancet Infect Dis. 2020;20(8):911-919. doi:10.1016/S1473-3099(20)30287-5
  • 6. Sinha IP, Harwood R, Semple MG, et al. COVID-19 infection in children. Lancet Respir Med. 2020;8(5):446-447. doi:10.1016/S2213-2600(20)30152-1
  • 7. Nikolopoulou GB, Maltezou HC. COVID-19 in Children: Where do we Stand?. Arch Med Res. 2022;53(1):1-8. doi:10.1016/j.arcmed.2021.07.002
  • 8. Li H, Liu Z, Ge J. Scientific research progress of COVID-19/SARS-CoV-2 in the first five months. J Cell Mol Med. 2020;24(12):6558-6570. doi:10.1111/jcmm.15364
  • 9. Dorjee K, Kim H, Bonomo E, Dolma R. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients. PLoS One. 2020;15(12):e0243191. Published 2020 Dec 7. doi:10.1371/journal.pone.0243191
  • 10. Chen J, Jiang Q, Xia X, et al. Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation. Aging Cell. 2020;19(7):e13168. doi:10.1111/acel.13168
  • 11. Felsenstein S, Hedrich CM. COVID-19 in children and young people. Lancet Rheumatol. 2020;2(9):e514-e516. doi:10.1016/S2665-9913(20)30212-5
  • 12. Lee PI, Hu YL, Chen PY, Huang YC, Hsueh PR. Are children less susceptible to COVID-19?. J Microbiol Immunol Infect. 2020;53(3):371-372. doi:10.1016/j.jmii.2020.02.011
  • 13. Lee PI, Hu YL, Chen PY,Huang YC, Hsueh PR. Are children less susceptible to COVID-19? Microbiol Immunol Infect. 2020;53(3):371-372. doi:10.1016/j.jmii.2020.02.011
  • 14. Fang F, Luo XP. [Facing the pandemic of 2019 novel coronavirus infections: the pediatric perspectives]. Zhonghua Er Ke Za Zhi. 2020 Feb 2;58(2):81-85. Chinese. doi: 10.3760/cma.j.issn.0578-1310.2020.02.001.
  • 15. Bunyavanich S, Do A, Vicencio A. Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults. JAMA. 2020;323(23):2427-2429. doi:10.1001/jama.2020.8707
  • 16. National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases. CDC COVID-19 Science Briefs [Internet]. Atlanta (GA): Centers for Disease Control and Prevention (US); 2020-. Science Brief: Transmission of SARS-CoV-2 in K-12 Schools and Early Care and Education Programs – Updated. [Updated 2021 Dec 17]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK570438/
  • 17. Luca Cristiani, Enrica Mancino, Luigi Matera et all European Respiratory Journal 2020 55: 2000749; doi: 10.1183/13993003.00749-2020.
  • 18. de Bree LCJ, Koeken VACM, Joosten LAB, et al. Non-specific effects of vaccines: Current evidence and potential implications. Semin Immunol. 2018;39:35-43. doi:10.1016/j.smim.2018.06.002
  • 19. Benn CS, Netea MG, Selin LK, Aaby P. A small jab - a big effect: nonspecific immunomodulation by vaccines. Trends Immunol. 2013;34(9):431-439. doi:10.1016/j.it.2013.04.004
  • 20. Jin XM, Xu X. [The Society of Pediatrics, Chinese Medical Association-an intensive training programme for developmental and behavioral pediatrics]. Zhonghua Er Ke Za Zhi. 2013 Nov;51(11):879-80. Chinese.
  • 21. Karbuz A, Akkoc G, Bedir Demirdag T, et al. Epidemiological, Clinical, and Laboratory Features of Children With COVID-19 in Turkey. Front Pediatr. 2021;9:631547. Published 2021 May 7. doi:10.3389/fped.2021.631547
  • 22. Lu X, Zhang L, Du H, et al. SARS-CoV-2 Infection in Children. N Engl J Med. 2020;382(17):1663-1665. doi:10.1056/NEJMc2005073
  • 23. Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020;145(6): e20200702. doi:10.1542/peds.2020-0702
  • 24. Ding Y, Yan H, Guo W. Clinical Characteristics of Children With COVID-19: A Meta-Analysis. Front Pediatr. 2020;8:431. Published 2020 Jul 3. doi:10.3389/fped.2020.00431
  • 25. Hoang A, Chorath K, Moreira A, et al. COVID-19 in 7780 pediatric patients: A systematic review. E Clinical Medicine. 2020;24:100433. Published 2020 Jun 26. doi:10.1016/j.eclinm.2020.100433
  • 26. Korkmaz MF, Türe E, Dorum BA, Kılıç ZB. The Epidemiological and Clinical Characteristics of 81 Children with COVID-19 in a Pandemic Hospital in Turkey: an Observational Cohort Study. J Korean Med Sci. 2020;35(25):e236. Published 2020 Jun 29. doi:10.3346/jkms.2020.35.e236
  • 27. Cura Yayla BC, Özsürekçi Y, Aykaç K, et al. Characteristics and Management of Children with COVID-19 in Turkey. Balkan Med J. 2020;37(6):341-347. doi:10.4274/ balkanmedj.galenos.2020.2020.7.52
  • 28. Mustafa NM, A Selim L. Characterisation of COVID-19 Pandemic in Paediatric Age Group: A Systematic Review and Meta-Analysis. J Clin Virol. 2020;128:104395. doi:10.1016/j.jcv.2020.104395
There are 28 citations in total.

Details

Primary Language Turkish
Subjects Health Care Administration
Journal Section Sözlü Bildiriler
Authors

Mehtap Akça This is me

Berfin Özgökçe Özmen This is me

Nihan Özel Erçel This is me

Necdet Kuyucu This is me

Publication Date June 30, 2022
Submission Date March 8, 2022
Acceptance Date March 10, 2022
Published in Issue Year 2022 Volume: 15 Issue: (Özel Sayı-1) 21. Mersin Pediatri Günleri Bildiri Kitabı

Cite

APA Akça, M., Özgökçe Özmen, B., Özel Erçel, N., Kuyucu, N. (2022). Çocuklarda COVİD-19 ile ilişkili Çoklu Sistemik İnflamatuvar Sendrom. Mersin Üniversitesi Sağlık Bilimleri Dergisi, 15((Özel Sayı-1) 21. Mersin Pediatri Günleri Bildiri Kitabı), 170-183.
AMA Akça M, Özgökçe Özmen B, Özel Erçel N, Kuyucu N. Çocuklarda COVİD-19 ile ilişkili Çoklu Sistemik İnflamatuvar Sendrom. Mersin Univ Saglık Bilim derg. June 2022;15((Özel Sayı-1) 21. Mersin Pediatri Günleri Bildiri Kitabı):170-183.
Chicago Akça, Mehtap, Berfin Özgökçe Özmen, Nihan Özel Erçel, and Necdet Kuyucu. “Çocuklarda COVİD-19 Ile ilişkili Çoklu Sistemik İnflamatuvar Sendrom”. Mersin Üniversitesi Sağlık Bilimleri Dergisi 15, no. (Özel Sayı-1) 21. Mersin Pediatri Günleri Bildiri Kitabı (June 2022): 170-83.
EndNote Akça M, Özgökçe Özmen B, Özel Erçel N, Kuyucu N (June 1, 2022) Çocuklarda COVİD-19 ile ilişkili Çoklu Sistemik İnflamatuvar Sendrom. Mersin Üniversitesi Sağlık Bilimleri Dergisi 15 (Özel Sayı-1) 21. Mersin Pediatri Günleri Bildiri Kitabı 170–183.
IEEE M. Akça, B. Özgökçe Özmen, N. Özel Erçel, and N. Kuyucu, “Çocuklarda COVİD-19 ile ilişkili Çoklu Sistemik İnflamatuvar Sendrom”, Mersin Univ Saglık Bilim derg, vol. 15, no. (Özel Sayı-1) 21. Mersin Pediatri Günleri Bildiri Kitabı, pp. 170–183, 2022.
ISNAD Akça, Mehtap et al. “Çocuklarda COVİD-19 Ile ilişkili Çoklu Sistemik İnflamatuvar Sendrom”. Mersin Üniversitesi Sağlık Bilimleri Dergisi 15/(Özel Sayı-1) 21. Mersin Pediatri Günleri Bildiri Kitabı (June 2022), 170-183.
JAMA Akça M, Özgökçe Özmen B, Özel Erçel N, Kuyucu N. Çocuklarda COVİD-19 ile ilişkili Çoklu Sistemik İnflamatuvar Sendrom. Mersin Univ Saglık Bilim derg. 2022;15:170–183.
MLA Akça, Mehtap et al. “Çocuklarda COVİD-19 Ile ilişkili Çoklu Sistemik İnflamatuvar Sendrom”. Mersin Üniversitesi Sağlık Bilimleri Dergisi, vol. 15, no. (Özel Sayı-1) 21. Mersin Pediatri Günleri Bildiri Kitabı, 2022, pp. 170-83.
Vancouver Akça M, Özgökçe Özmen B, Özel Erçel N, Kuyucu N. Çocuklarda COVİD-19 ile ilişkili Çoklu Sistemik İnflamatuvar Sendrom. Mersin Univ Saglık Bilim derg. 2022;15((Özel Sayı-1) 21. Mersin Pediatri Günleri Bildiri Kitabı):170-83.

MEU Journal of Health Sciences Assoc was began to the publishing process in 2008 under the supervision of Assoc. Prof. Gönül Aslan, Editor-in-Chief, and affiliated to Mersin University Institute of Health Sciences. In March 2015, Prof. Dr. Caferi Tayyar Şaşmaz undertook the Editor-in Chief position and since then he has been in charge.

Publishing in three issues per year (April - August - December), it is a multisectoral refereed scientific journal. In addition to research articles, scientific articles such as reviews, case reports and letters to the editor are published in the journal. Our journal, which has been published via e-mail since its inception, has been published both online and in print. Following the Participation Agreement signed with TÜBİTAK-ULAKBİM Dergi Park in April 2015, it has started to accept and evaluate online publications.

Mersin University Journal of Health Sciences have been indexed by Turkey Citation Index since November 16, 2011.

Mersin University Journal of Health Sciences have been indexed by ULAKBIM Medical Database from the first issue of 2016.

Mersin University Journal of Health Sciences have been indexed by DOAJ since October 02, 2019.

Article Publishing Charge Policy: Our journal has adopted an open access policy and there is no fee for article application, evaluation, and publication in our journal. All the articles published in our journal can be accessed from the Archive free of charge.

154561545815459

Creative Commons Lisansı
This work is licensed with Attribution-NonCommercial 4.0 International.